Transcranial Electric Stimulation for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Transcranial Electric Stimulation for Health & Longevity

Created on 07/03/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

Passing weak electric currents through the scalp to gently shift brain activity. Best-supported uses are easing low mood and modest cognitive gains in older adults or those with early decline, especially when paired with mental training or exercise. Weaker and mixed in already-healthy people. Side effects are minor; long-term home-use safety is unstudied. (Full Review)

Protocol

Current
1–2 mA
Anodal over left dorsolateral prefrontal cortex or task-relevant region; ramp current up/down over 10–30 seconds
Session
20–30 min
Per session; for alternating current, match frequency to brain rhythm — theta (~4–8 Hz) for memory, gamma (~40 Hz) for attention
Course
10–20 sessions
Daily or near-daily; multiple spaced sessions over 1–4 weeks favored over a single long session for durable effects
Time to effect
Durable benefit
1–4 weeks
Durable cognitive or mood benefits typically require a multi-session course
Acute effects
1 to few sessions
Some acute effects (mood lift, task performance) can appear within a single session or after a few sessions
Effects fade
Weeks to months
Effects then fade over subsequent weeks to months, prompting periodic repeat courses

Benefits

Contraindications
  • Epilepsy or seizure history (uncontrolled epilepsy: absolute)
  • Implanted electronic devices (deep brain stimulators, pacemakers, cochlear implants); any implanted active neurostimulation device: absolute
  • Cranial metal
  • Pregnancy
  • Active scalp skin disease
  • Personal/family history of bipolar disorder (for excitatory prefrontal montages)
    •
Key Interactions
  • CNS stimulants and drugs lowering seizure threshold (bupropion, tramadol, certain antipsychotics, theophylline)
  • Antidepressants and mood medications
  • OTC agents affecting the nervous system (high-dose caffeine, sedating antihistamines)
  • Supplement interactions (high-dose caffeine, nicotine, glutamate/GABA-affecting agents)
  • Other interventions (cognitive training, aerobic exercise, transcranial magnetic stimulation)
    •

Risk & Side Effects

  • High: Transient skin sensations and local irritation
    •
  • Medium: Headache, fatigue, and nausea; phosphenes and transient visual/perceptual effects
    •
  • Low: Unintended cognitive trade-offs; mood changes and agitation
    •
  • Speculative: Unknown long-term effects of chronic home use; seizure risk
    •

Monitoring

Marker Target Why
Standardized cognitive test score (e.g., n-back, RAVLT) Improvement over personal baseline Tracks whether the target cognitive function changes
Validated mood scale (e.g., PHQ-9) Reduction over baseline; PHQ-9 < 5 (minimal) Tracks mood response when used for low mood
Electrode-site skin condition No persistent redness, pain, or breakdown Detects irritation or early burns
Seizure-threshold screening (history/EEG if indicated) No epileptiform activity Screens higher-risk users before excitatory montages

Cadence: Screen and baseline-test before starting; check tolerability and skin condition after each session; reassess cognitive and mood outcomes at the end of a course (e.g., after 2–4 weeks), then every 3–6 months if courses are repeated.

Qualitative Assessment

  • Subjective sharpness of memory, focus, and mental clarity
  • Mood, motivation, and emotional stability
  • Sleep quality and daytime energy
  • Task-specific performance (e.g., work output, reaction time in trained tasks)
  • Tolerability and comfort during and after sessions
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.